Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose Oxidase Nasal Spray for Common Cold
NCT01883440Phase 2Completed
- Start
- Jan 2013
- Primary completion
- Aug 2013
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glucose oxidase in common cold (2 arms). Primary endpoints: Sum of All Symptoms in Viruspositive Persons at 1 week and Sum of All Symptoms of All Persons That Fullfilled the Study at 7 days. Started Jan 2013; status: completed.
02
Drugs
glucose oxidase
03
Conditions
common cold
Beyond the preview
Go deeper on NCT01883440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01883440.